Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use With Control-IQ Technology in Type 2 Diabetes.
Journal: Clinical diabetes : a publication of the American Diabetes Association
Published: October 21, 2024
Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes.
Journal: Clinical diabetes : a publication of the American Diabetes Association
Published: January 17, 2024
Showing 1-2 of 2
Last Updated: 09/26/2026